Grufity logo
Grufity logo

Latest ADAR1 Capital Management, LLC Stock Portfolio

$1.70Billion– No. of Holdings #290

ADAR1 Capital Management, LLC Performance:
2026 Q1: 0.67%YTD: 0.67%2025: 63.95%
Performance for 2026 Q1 is 0.67%, and YTD is 0.67%, and 2025 is 63.95%.

About ADAR1 Capital Management, LLC and 13F Hedge Fund Stock Holdings

On 2026-05-18, the fund reported it's updated stock portfolio. In the 13F Holdings report, ADAR1 Capital Management, LLC reported an equity portfolio of $1.7 Billions as of 31 Mar, 2026.

The top stock holdings of ADAR1 Capital Management, LLC are , PTGX, ROIV. The fund has invested 9.1% of it's portfolio in ABIVAX SA and 6.2% of portfolio in PROTAGONIST THERAPEUTICS INC.

The fund managers got completely rid off AVIDITY BIOSCIENCES INC (RNA), RAPT THERAPEUTICS INC (RAPT) and CIDARA THERAPEUTICS INC (CDTX) stocks. They significantly reduced their stock positions in CRESCENT BIOPHARMA INC., FULCRUM THERAPEUTICS INC (FULC) and CYBIN INC (CYBN). ADAR1 Capital Management, LLC opened new stock positions in BEAM THERAPEUTICS INC (BEAM), VIR BIOTECHNOLOGY INC (VIR) and DBV TECHNOLOGIES S A (DBVT). The fund showed a lot of confidence in some stocks as they added substantially to OPUS GENETICS INC (OCUP), PEPGEN INC (PEPG) and DENALI THERAPEUTICS INC (DNLI).
ADAR1 Capital Management, LLC Equity Portfolio Value
Last Reported on: 18 May, 2026

ADAR1 Capital Management, LLC Annual Return Estimates Vs S&P 500

Our best estimate is that ADAR1 Capital Management, LLC made a return of 0.67% in the last quarter. In trailing 12 months, it's portfolio return was 77.51%.
  • Performance
  • S&P 500

New Buys

Ticker$ Bought
beam therapeutics inc34,467,100
vir biotechnology inc24,592,600
dbv technologies s a21,158,800
helix acquisition corp iii10,300,000
moonlake immunotherapeutics8,521,030
maplight therapeutics inc7,621,900
damora therapeutics inc7,226,100
prime medicine inc6,867,020
New stocks bought by ADAR1 Capital Management, LLC

Additions

Ticker% Inc.
opus genetics inc4,522
pepgen inc4,263
denali therapeutics inc3,490
pliant therapeutics inc3,401
inspire med sys inc2,601
relmada therapeutics inc1,364
enliven therapeutics inc998
spyre therapeutics inc893
Additions to existing portfolio by ADAR1 Capital Management, LLC

Reductions

Ticker% Reduced
crescent biopharma inc.-91.7
fulcrum therapeutics inc-89.59
cybin inc-86.88
corvus pharmaceuticals inc-81.13
immix biopharma inc-80.00
aclaris therapeutics inc-78.43
teleflex incorporated-73.72
maze therapeutics inc-72.1
ADAR1 Capital Management, LLC reduced stake in above stock

Sold off

Ticker$ Sold
atai beckley nv-3,735,160
grace therapeutics inc-2,221,280
aa mission acquisition corp-6,171,090
avidity biosciences inc-39,421,500
cleancore solutions inc-135,715
rapt therapeutics inc-17,262,800
bridgebio oncology therapeut-2,832,620
astria therapeutics inc-2,271,860
ADAR1 Capital Management, LLC got rid off the above stocks

Sector Distribution

ADAR1 Capital Management, LLC has about 67.8% of it's holdings in Healthcare sector.

  • Healthcare
  • Others
Sector%
Healthcare67.8
Others30.6

Market Cap. Distribution

ADAR1 Capital Management, LLC has about 12.4% of it's portfolio invested in the large-cap and mega-cap stocks.

  • MID-CAP
  • UNALLOCATED
  • SMALL-CAP
  • LARGE-CAP
  • MICRO-CAP
  • NANO-CAP
Category%
MID-CAP33.3
UNALLOCATED30.6
SMALL-CAP15.8
LARGE-CAP12.4
MICRO-CAP6.1
NANO-CAP1.2

Stocks belong to which Index?

About 43.4% of the stocks held by ADAR1 Capital Management, LLC either belong to S&P 500 or RUSSELL 2000 index.

  • Others
  • RUSSELL 2000
  • S&P 500
Index%
Others56.5
RUSSELL 200040.9
S&P 5002.5
Top 5 Winners (%)%
TNGX
tango therapeutics inc
92.4 %
ELDN
eledon pharmaceuticals inc
79.8 %
CNTX
context therapeutics inc
78.2 %
ACLX
arcellx inc
74.9 %
ONTX
traws pharma inc
61.9 %
Top 5 Winners ($)$
ROIV
roivant sciences ltd
20.1 M
PTGX
protagonist therapeutics inc
18.5 M
TERN
terns pharmaceuticals inc
9.0 M
cg oncology inc
5.8 M
enliven therapeutics inc
4.3 M
Top 5 Losers (%)%
QNCX
quince therapeutics inc
-96.8 %
GOSS
gossamer bio inc
-88.0 %
BCAB
bioatla inc
-69.5 %
KALA
kala bio inc
-68.9 %
PEPG
pepgen inc
-57.8 %
Top 5 Losers ($)$
abivax sa
-31.9 M
INSP
inspire med sys inc
-8.5 M
CRNX
crinetics pharmaceuticals in
-7.4 M
lexeo therapeutics inc
-6.0 M
ADGI
invivyd inc
-4.5 M

ADAR1 Capital Management, LLC Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of ADAR1 Capital Management, LLC

ADAR1 Capital Management, LLC has 290 stocks in it's portfolio. About 39.6% of the portfolio is in top 10 stocks. proved to be the most loss making stock for the portfolio. ROIV was the most profitable stock for ADAR1 Capital Management, LLC last quarter.

Last Reported on: 18 May, 2026
TickerNamesorted ascending% PortfolioShares Held$ ValueType% ChangeOptions